Zhao, J., Quan, H., Xie, C., & Lou, L. (2014). NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations. Blackwell Publishing Ltd.
Citação norma ChicagoZhao, Jie, Haitian Quan, Chengying Xie, and Liguang Lou. NL-103, a Novel Dual-targeted Inhibitor of Histone Deacetylases and Hedgehog Pathway, Effectively Overcomes Vismodegib Resistance Conferred By Smo Mutations. Blackwell Publishing Ltd, 2014.
MLA citiranjeZhao, Jie, Haitian Quan, Chengying Xie, and Liguang Lou. NL-103, a Novel Dual-targeted Inhibitor of Histone Deacetylases and Hedgehog Pathway, Effectively Overcomes Vismodegib Resistance Conferred By Smo Mutations. Blackwell Publishing Ltd, 2014.